Literature DB >> 7263564

Plasma concentration monitoring of aminoglycosides.

F Follath, M Wenk, S Vozeh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263564     DOI: 10.1093/jac/8.suppl_a.37

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  Aminoglycoside-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

2.  Population pharmacokinetics of tobramycin.

Authors:  L Aarons; S Vozeh; M Wenk; P Weiss; F Follath
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test.

Authors:  H Lagast; A Pascual-Lopez; P Dejace; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Homogeneous enzyme immunoassay for netilmicin.

Authors:  M Wenk; R Hemmann; F Follath
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

5.  Comparison of venous and capillary blood sampling for the clinical determination of tobramycin serum concentrations.

Authors:  A S Lewis; G Taylor; H O Williams; M H Lewis
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

6.  Radioenzymatic assays for aminoglycosides with kanamycin 6'-acetyltransferase.

Authors:  A Weber; A L Smith; K E Opheim
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

Review 7.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.